Indian journal of Medical Biochemistry

Register      Login

VOLUME 22 , ISSUE 2 ( July-December, 2018 ) > List of Articles

RESEARCH ARTICLE

Correlation of Serum Cholinesterase with Lipid Indices in Type 2 Diabetes Mellitus Patients in McGann Teaching Hospital, Shimoga, Karnataka, India

Hemantha Kumara DS, Gurupadappa K

Keywords : Fasting blood glucose, Lipid indices, Serum cholinesterase, Type 2 diabetes mellitus.,Cardiovascular disease

Citation Information : DS HK, K G. Correlation of Serum Cholinesterase with Lipid Indices in Type 2 Diabetes Mellitus Patients in McGann Teaching Hospital, Shimoga, Karnataka, India. Indian J Med Biochem 2018; 22 (2):154-156.

DOI: 10.5005/jp-journals-10054-0074

License: CC BY-NC 3.0

Published Online: 00-12-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: Type 2 diabetes mellitus (DM) is a cluster of conditions categorized by longstanding hyperglycemia accompanying with disturbances of carbohydrate, lipid and protein metabolism due to absolute/relative deficiency of insulin secretion and/or its action. Serum cholinesterase is an enzyme, which has been associated with diabetes, hypertension, cardio, and vascular disease and also it has a role in the metabolism of lipoproteins. Few studies showed that serum cholinesterase activity has been positively’ correlated with lipid indices and blood lipoprotein levels. Aim and objectives: To estimate serum cholinesterase levels in clinically diagnosed type 2 DM patients and to evaluate the correlation between true cholinesterase level and lipid indices in the type II diabetes patients. Materials and methods: Total 120 subjects were involved in this study. Out of which 60 were clinically diagnosed type II diabetes mellitus cases, and 60 were age and sex-matched healthy controls. Serum cholinesterase enzyme activity, fasting blood glucose levels and lipid profile and indices analysis done in event-eelated brain activation (ERBA) autoanalyzer. Statistical data analysis was performed by using Statistical Package for the Social Sciences (SPSS) 19.2 software. Results: The enzyme cholinesterase activity levels raised in cases compared to healthy controls. The enzyme cholinesterase levels in cases revealed 9576 ± 1542.78 (IU/L) and in controls was 6783.9 ± 798.98 (IU/L). The enzyme cholinesterase showed a positive correlation with every lipid indices namely total cholesterol, triglycerides, low-density lipoprotein-cholesterol (LDL-C), total cholesterol to high-density lipoprotein-cholesterol (HDL-C) ratio and negative correlation with HDL-C in cases as compared to healthy controls. Conclusion: The outcome of our study showed that serum (true) cholinesterase level may assist as a budding risk assessment indicator of cardiovascular disease in type 2 DM.


PDF Share
  1. Bennett PH, Knowles WC. Definition, diagnosis and classification of diabetes mellitus and glucose homeostasis. Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ, editors. Joslin's Diabetes Mellitus. 14th edition. Boston: Ovid Technologies, Inc. 2005; p 331-333.
  2. Park K et al. Diabetes mellitus, in park`s text book of preventive and social medicine, 24rd edition. 2013;341-345.
  3. Moghadam RH, Latiffah A. Investigation of lipid profiles and lipid peroxidation in patients with type 2 diabetes. European Journal of Scientific Research. 2009;28(1):6-13.
  4. Howard BV. Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians. Diabetes Care 1993;16:284-291.
  5. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. American Journal of Physiology-Cell Physiology. 1996 Nov 1;271(5):C1424- C1437.
  6. Davis L, Britten JJ, Morgan M. Cholinesterase Its significance in anaesthetic practice. Anaesthesia. 1997 Mar;52(3):244-260.
  7. Ostergaard D, Viby-Mogensen J, Hanel HK, Skovgaard LT. Half-life of plasma cholinesterase. Acta Anaesthesiol Scand. 1988;32:266-269.
  8. Pan Y, Muzyka JL, Zhan CG. Model of human butyrylcholinesterase tetramer by homology modeling and dynamics simulation. J Phys Chem B. 2009;113:6543-6552.
  9. Paes AM, Carniatto SR, Francisco FA, Brito NA, Mathias PC. Acetylcholinesterase activity changes on visceral organs of VMH lesion-induced obese rats. Int J Neurosci. 2006;116:1295-1302.
  10. Cucuianu M, Nistor T, Hâncu N, Orbai P, Muscurel C, Stoian I. Serum cholinesterase activity correlates with serum insulin, Cpeptide and free fatty acids levels in patients with type 2 diabetes. Rom J Intern Med. 2002;40:43-51.
  11. Kutty KM, Payne RH. Serum pseudocholinesterase and verylowdensity lipoprotein metabolism. J Clin Lab Anal. 1994;8: 247-250.
  12. Johansen AE-M, Nielsen D, Andersen G, Hamid YH, Jensen DP, Glümer C, et al Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion. Diabetologia 2004;47:1437-1441.
  13. Iwasaki T, Yoneda M, Nakajima A, Terauchi Y. Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance. Internal Medicine. 2007;46(19):1633-1639.
  14. Sniderman AD, Scantlebury T, Cianflone K. Hypertriglyceridemic hyperapoB: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 2001;135:447-59.
  15. Alcantara VM, Chautard-Freire-Maia EA, Scartezini M, Cerci MS, Braun-Prado K, Picheth G. Butyrylcholinesterase activity and risk factors for coronary artery disease. Scandinavian journal of clinical and laboratory investigation. 2002 Jan 1;62(5):399-404.
  16. Sridhar GR, Nirmala G, Apparao A, Madhavi AS, Sreelatha S, Rani JS, et al. Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach. Lipids in health and disease. 2005 Dec;4(1):18.
  17. Cwiertnia MM, Alcântara VM, Réa RR, Faria AC, Picheth G, Scartezini M, et al. Butyrylcholinesterase and diabetes mellitus in the CHE2 C5-and CHE2 C5+ phenotypes. Arquivos Brasileiros de Endocrinologia & Metabologia. 2010 Feb;54(1):60-67.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.